<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is a <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e> with <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Advances in medicine and surgery have increased the average lifespan of classically affected patients </plain></SENT>
<SENT sid="2" pm="."><plain>Serious visual and/or musculoskeletal impairment often has detrimental effects on day-to-day activities and quality of life </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients suffer from many problems at younger ages and with higher frequencies than the general population because of the degenerative nature of the <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">genetic condition</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>In classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, changes are caused by mutations in the fibrillin-1 gene (FBN1) </plain></SENT>
<SENT sid="5" pm="."><plain>Mutations in the fibrillin-2 gene were discovered in individuals with a phenotypically related <z:e sem="disease" ids="C0242354" disease_type="Disease or Syndrome" abbrv="">disorder, congenital</z:e> contractural <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Some of the clinical manifestations of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> cannot be explained by mechanical properties alone </plain></SENT>
<SENT sid="7" pm="."><plain>Recently, mutations in the genes required for transforming growth factor-beta signaling (TGFBR1 and TGFBR2) have been found in several disorders with varying degrees of overlap with classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>, including Loeys-Dietz syndrome and familial thoracic <z:hpo ids='HP_0004942'>aortic aneurysms</z:hpo> and dissections </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> is a disorder that is variable in its phenotypic expression </plain></SENT>
<SENT sid="9" pm="."><plain>Specific information about mutations in the large FBN1 gene will give rise to more information about the phenotype-genotype correlations </plain></SENT>
<SENT sid="10" pm="."><plain>Possible molecular mechanisms for the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> will be discussed which may assist healthcare professionals to control environmental factors that provoke individual complications in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
</text></document>